- 新聞
- 活動
- 文獻發表
- 外部來源
-
2022Feb
23
Interview with HCmed's Project Manager, Ellie ChenAs the head of the Project Management Department, Ellie Chen this week shares her experience working at HCmed Innovations Co., Ltd.
-
2022Jan
10
Interview with HCmed's BD Manager & Scientist, Hernan Cuevas BrunHernan Cuevas Brun, Business Development Manager and Aerosol Drug Delivery Scientist at HCmed Innovations, this week shares his experience working in the industry of developing nebulizers and combination products.
-
2021Nov
19
Interview with HCmed's R&D Director, Yuan-Ming HsuThis week Yuan-Ming Hsu, Director of the R&D Department at HCmed Innovations, shares his thoughts and experience working in the medical device industry.
-
2021Oct
18
Interview with HCmed's COO, Leon TsaiHCmed's COO, Leon Tsai, shares his experience in the development of mesh nebulizer and his motivation to improve these devices to provide more effective solutions for inhalation therapy.
-
2021Aug
18
HCmed and Cellics Announce Collaboration on Nebulized Nanosponges for the Treatment of Bacterial Infections and Inflammatory DiseasesHCmed Innovations Co., Ltd. (HCmed) and Cellics Therapeutics, Inc. (Cellics) have initiated a collaboration, introducing inhalation therapy for the delivery of nanospages.
-
2021Jul
21
HCmed Wins 2021 Taiwan BIO Award for Growth PotentialHCmed Innovations Co., Ltd. (HCmed) is honored to be listed as one the winners awarded for its growth potential.
-
2021Jul
20
HCmed Receives FDA 510(k) Approval for PulmogineHCmed Innovations is delighted to announce that it has received US Food and Drug Administration (FDA) 510(k) clearance for its portable mesh nebulizer, Pulmogine.
-
2021Jun
25
HCmed Signs Agreement With Cathay For IPOHCmed Innovations (HCmed) signed an agreement with Cathay Securities on June 21st, 2021, to prepare for its initial public offering (IPO).
-
2021May
04
HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL BehringCompanies Initiated Phase I trial in December 2020
-
2020Nov
11
HCmed Joins the 3rd China International Import Expo (CIIE)In its second consecutive year showcasing as an invited guest of I-Campus at the CIIE, HCmed Innovations was delighted to introduce its new smart device prototype
-
2020Oct
19
Pulmogine Vibrating Mesh Nebulizer is now available in ChinaWe are delighted to announce that SinoMedCare BioTech Co., Ltd. (SMC) has become the exclusive distributor of our vibrating mesh nebulizer Pulmogine in China.
-
2020Jul
02
HCmed Innovations Co., Ltd. is committed to help in the fight against the COVID-19 pandemicHCmed is ready to join the fight. Our mesh nebulizers are highly efficient customizable devices that deliver drugs deep into the lungs.
-
2020May
21
HCmed’s Pulmogine Mesh Nebulizer receives NMPA ApprovalHCmed Innovations is pleased to inform that it has received NMPA approval from the National Medical Products Administration in China for its handheld mesh nebulizer, Pulmogine.
-
2020May
21
HCmed’s Pulmogine Mesh Nebulizer receives NMPA ApprovalHCmed Innovations is pleased to inform that it has received NMPA approval from the National Medical Products Administration in China for its handheld mesh nebulizer, Pulmogine.
-
2019Nov
21
HCmed Joins the China International Import Expo and China Healthcare SummitAiming to continue expanding its global presence and promoting its new brand “Pulmogine,” HCmed Innovations participated at two main events held in China this month.